These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 26844505)

  • 1. Efficacy and Safety of Bisphosphonates for Low Bone Mineral Density After Kidney Transplantation: A Meta-Analysis.
    Kan SL; Ning GZ; Chen LX; Zhou Y; Sun JC; Feng SQ
    Medicine (Baltimore); 2016 Feb; 95(5):e2679. PubMed ID: 26844505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of bisphosphonate and its supplements for bone loss in kidney transplant recipients: a systematic review and network meta-analysis.
    Yang Y; Qiu S; Deng L; Tang X; Li X; Wei Q; Fu P
    BMC Nephrol; 2018 Oct; 19(1):269. PubMed ID: 30340537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonates for prevention of osteopenia in kidney-transplant recipients: a systematic review of randomized controlled trials.
    Wang J; Yao M; Xu JH; Shu B; Wang YJ; Cui XJ
    Osteoporos Int; 2016 May; 27(5):1683-90. PubMed ID: 26733377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates for osteoporosis in primary biliary cirrhosis.
    Rudic JS; Giljaca V; Krstic MN; Bjelakovic G; Gluud C
    Cochrane Database Syst Rev; 2011 Dec; (12):CD009144. PubMed ID: 22161446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonates for osteoporosis in people with cystic fibrosis.
    Conwell LS; Chang AB
    Cochrane Database Syst Rev; 2009 Oct; (4):CD002010. PubMed ID: 19821288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate therapy for osteogenesis imperfecta.
    Phillipi CA; Remmington T; Steiner RD
    Cochrane Database Syst Rev; 2008 Oct; (4):CD005088. PubMed ID: 18843680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of bisphosphonates on bone loss in the first year after renal transplantation--a meta-analysis of randomized controlled trials.
    Mitterbauer C; Schwarz C; Haas M; Oberbauer R
    Nephrol Dial Transplant; 2006 Aug; 21(8):2275-81. PubMed ID: 16574684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Different Bisphosphonates for Bone Loss Prevention in Kidney Transplant Recipients: A Network Meta-Analysis of Randomized Controlled Trials.
    Yang Y; Qiu S; Tang X; Li XR; Deng LH; Wei Q; Fu P
    Chin Med J (Engl); 2018 Apr; 131(7):818-828. PubMed ID: 29578126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonate therapy for osteogenesis imperfecta.
    Dwan K; Phillipi CA; Steiner RD; Basel D
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005088. PubMed ID: 27760454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates for osteoporosis in people with cystic fibrosis.
    Conwell LS; Chang AB
    Cochrane Database Syst Rev; 2012 Apr; (4):CD002010. PubMed ID: 22513903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates in multiple myeloma: a network meta-analysis.
    Mhaskar R; Redzepovic J; Wheatley K; Clark OA; Miladinovic B; Glasmacher A; Kumar A; Djulbegovic B
    Cochrane Database Syst Rev; 2012 May; (5):CD003188. PubMed ID: 22592688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonate therapy for osteogenesis imperfecta.
    Dwan K; Phillipi CA; Steiner RD; Basel D
    Cochrane Database Syst Rev; 2014 Jul; (7):CD005088. PubMed ID: 25054949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teriparatide versus bisphosphonates for treatment of postmenopausal osteoporosis: A meta-analysis.
    Yuan F; Peng W; Yang C; Zheng J
    Int J Surg; 2019 Jun; 66():1-11. PubMed ID: 30890377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of bisphosphonates for osteoporosis or osteopenia in Crohn's disease: a meta-analysis.
    Guo Z; Wu R; Gong J; Zhu W; Li Y; Li N; Li J
    Dig Dis Sci; 2013 Apr; 58(4):915-22. PubMed ID: 23179146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials.
    Li M; Ge Z; Zhang B; Sun L; Wang Z; Zou T; Chen Q
    Arch Osteoporos; 2024 Sep; 19(1):89. PubMed ID: 39312040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of bisphosphonates against osteoporosis in adult men: a meta-analysis of randomized controlled trials.
    Chen L; Wang G; Zheng F; Zhao H; Li H
    Osteoporos Int; 2015 Sep; 26(9):2355-63. PubMed ID: 25944731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates for osteoporosis in people with cystic fibrosis.
    Conwell LS; Chang AB
    Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD002010. PubMed ID: 24627308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of medical therapy for low bone mineral density in patients with inflammatory bowel disease: a meta-analysis and systematic review.
    Melek J; Sakuraba A
    Clin Gastroenterol Hepatol; 2014 Jan; 12(1):32-44.e5. PubMed ID: 23981521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions for preventing bone disease in kidney transplant recipients.
    Palmer SC; McGregor DO; Strippoli GF
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005015. PubMed ID: 17636784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions for preventing bone disease in kidney transplant recipients: a systematic review of randomized controlled trials.
    Palmer SC; Strippoli GF; McGregor DO
    Am J Kidney Dis; 2005 Apr; 45(4):638-49. PubMed ID: 15806466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.